Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Inovio Pharma (INO)

16.94   1.57 (10.21%) 09-27 22:06
Open: 15.85 Pre. Close: 15.37
High: 16.96 Low: 15.86
Volume: 13,539,826 Market Cap: 2,838M
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. The company is headquartered in San Diego, California and currently employs 281 full-time employees. The firm's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. The company has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.968 - 17.07 17.07 - 17.169
Low: 15.629 - 15.744 15.744 - 15.854
Close: 16.754 - 16.933 16.933 - 17.104

Technical analysis

as of: 2020-09-25 4:31:28 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 21.83     One year: 25.50
Support: Support1: 12.57    Support2: 8.78
Resistance: Resistance1: 18.69    Resistance2: 21.83
Pivot: 13.89
Moving Average: MA(5): 16.59     MA(20): 13.21
MA(100): 16.83     MA(250): 9.60
MACD: MACD(12,26): 0.50     Signal(9): -0.21
Stochastic oscillator: %K(14,3): 73.80     %D(3): 76.63
RSI: RSI(14): 57.13
52-week: High: 33.79  Low: 1.92  Change(%): 726.3
Average Vol(K): 3-Month: 2419798  10-Days: 3980967

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
INO has closed below upper band by 26.8%. Bollinger Bands are 33.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 27 Sep 2020
If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now - Motley Fool

Sat, 26 Sep 2020
Is Inovio Worth Buying During the Market Correction? - The Motley Fool

Fri, 25 Sep 2020
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Has Recovered 87.51% So Far, But Another 119.84% Gain Cannot Be Ruled Out - Marketing Sentinel

Wed, 23 Sep 2020
Why Inovio Pharmaceuticals Stock Is Down Today - Motley Fool

Tue, 22 Sep 2020
3 Critical Catalysts on the Way for Inovio - Motley Fool

Mon, 21 Sep 2020
Inovio Pharmaceuticals Stock Could See More Downside From $16 - Forbes

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 168
Shares Float (M) 164
% Held by Insiders 2.69
% Held by Institutions 29.41
Shares Short (K) 51,820
Shares Short P. Month (K) 38,400

Stock Financials

EPS -1.850
EPS Est This Year -0.950
EPS Est Next Year -1.200
Book Value (p.s.) 1.170
Profit Margin
Operating Margin -4045.74
Return on Assets (ttm) -22.8
Return on Equity (ttm) -184.5
Qtrly Rev. Growth 96.9
Gross Profit (p.s.) -0.490
Sales Per Share 0.016
EBITDA (p.s.) -0.637
Qtrly Earnings Growth
Operating Cash Flow (M) -94
Levered Free Cash Flow (M) -52

Stock Valuations

PE Ratio -9.16
PEG Ratio
Price to Book value 14.48
Price to Sales 1035.69
Price to Cash Flow -30.16

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.